Serum cholesterol and triglycerides in hematological malignancies

Acta Haematologica
A MariniF Ambrogi

Abstract

Serum levels of total cholesterol and triglycerides were studied in 202 patients affected by various hematological malignancies at the time of diagnosis. A hypocholesterolemia was found in 44% of patients affected by lymphoproliferative diseases and acute lymphoblastic leukemia, with an evident correlation with the clinical stage (5.7% of patients in nonadvanced stages, 67.8% in advanced stages). In acute and chronic myeloproliferative diseases, the overall incidence of hypocholesterolemia was 71%. In particular, a greater incidence of low cholesterol values was found in chronic myeloid leukemia and in idiopathic myelofibrosis than in polycythemia vera. No significant correlation was found in this group of diseases between the values of cholesterol and the main hematological parameters studied (WBC, number of circulating blasts, degree of splenomegaly, levels of hemoglobin, hematocrit). The incidence of significant alterations of triglycerides appeared negligible. It is thus possible to affirm that hypocholesterolemia constitutes an interesting biological aspect in hematological malignancies, and that total cholesterol could represent a parameter, even though secondary, in the follow-up of hematological neoplastic pathologies.

Citations

Jan 1, 1990·Social Science & Medicine·B CurbowJ Sonnega
Nov 13, 2001·British Journal of Haematology·T NeunteuflH Gisslinger
May 17, 2000·Journal of Hematotherapy & Stem Cell Research·K AllampallamA Raza
Jan 3, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Veena S GhalautP S Ghalaut
Jan 1, 1997·International Journal of Psychiatry in Medicine·G Shor-PosnerM K Baum
Dec 19, 2019·International Journal of Molecular Sciences·Jaideep ChaudharyIan R Corbin
Jul 1, 1997·American Journal of Hematology·J PandolfinoM S Tallman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.